
[ Tue, Sep 15th 2009 ] - Market Wire
[ Tue, Sep 15th 2009 ] - Market Wire
[ Tue, Sep 15th 2009 ] - Market Wire
[ Tue, Sep 15th 2009 ] - Market Wire
[ Tue, Sep 15th 2009 ] - Market Wire
[ Tue, Sep 15th 2009 ] - Market Wire

[ Mon, Sep 14th 2009 ] - Market Wire
[ Mon, Sep 14th 2009 ] - Market Wire
[ Mon, Sep 14th 2009 ] - Market Wire
[ Mon, Sep 14th 2009 ] - Market Wire
[ Mon, Sep 14th 2009 ] - Market Wire
[ Mon, Sep 14th 2009 ] - Market Wire

[ Fri, Sep 11th 2009 ] - Market Wire
[ Fri, Sep 11th 2009 ] - Market Wire
[ Fri, Sep 11th 2009 ] - Market Wire
[ Fri, Sep 11th 2009 ] - Market Wire
[ Fri, Sep 11th 2009 ] - Market Wire
[ Fri, Sep 11th 2009 ] - Market Wire

[ Thu, Sep 10th 2009 ] - Market Wire
[ Thu, Sep 10th 2009 ] - Market Wire
[ Thu, Sep 10th 2009 ] - Market Wire
[ Thu, Sep 10th 2009 ] - Market Wire
[ Thu, Sep 10th 2009 ] - Market Wire

[ Wed, Sep 09th 2009 ] - Market Wire
[ Wed, Sep 09th 2009 ] - Market Wire
[ Wed, Sep 09th 2009 ] - Market Wire
[ Wed, Sep 09th 2009 ] - Market Wire
[ Wed, Sep 09th 2009 ] - Market Wire
[ Wed, Sep 09th 2009 ] - Market Wire

[ Tue, Sep 08th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire
[ Tue, Sep 08th 2009 ] - Market Wire

[ Sun, Sep 06th 2009 ] - Market Wire

[ Fri, Sep 04th 2009 ] - Market Wire
[ Fri, Sep 04th 2009 ] - Market Wire
[ Fri, Sep 04th 2009 ] - Market Wire
[ Fri, Sep 04th 2009 ] - Market Wire
[ Fri, Sep 04th 2009 ] - Market Wire
[ Fri, Sep 04th 2009 ] - Market Wire

[ Thu, Sep 03rd 2009 ] - Market Wire
[ Thu, Sep 03rd 2009 ] - Market Wire
[ Thu, Sep 03rd 2009 ] - Market Wire
[ Thu, Sep 03rd 2009 ] - Market Wire
[ Thu, Sep 03rd 2009 ] - Market Wire
[ Thu, Sep 03rd 2009 ] - Market Wire

[ Wed, Sep 02nd 2009 ] - Market Wire
[ Wed, Sep 02nd 2009 ] - Market Wire
[ Wed, Sep 02nd 2009 ] - Market Wire
[ Wed, Sep 02nd 2009 ] - Market Wire
[ Wed, Sep 02nd 2009 ] - Market Wire
[ Wed, Sep 02nd 2009 ] - Market Wire

[ Tue, Sep 01st 2009 ] - Market Wire
[ Tue, Sep 01st 2009 ] - Market Wire
[ Tue, Sep 01st 2009 ] - Market Wire
[ Tue, Sep 01st 2009 ] - Market Wire
[ Tue, Sep 01st 2009 ] - Market Wire
[ Tue, Sep 01st 2009 ] - Market Wire

[ Mon, Aug 31st 2009 ] - Market Wire
[ Mon, Aug 31st 2009 ] - Market Wire
[ Mon, Aug 31st 2009 ] - Market Wire
[ Mon, Aug 31st 2009 ] - Market Wire
[ Mon, Aug 31st 2009 ] - Market Wire
[ Mon, Aug 31st 2009 ] - Market Wire

[ Fri, Aug 28th 2009 ] - Market Wire
[ Fri, Aug 28th 2009 ] - Market Wire
[ Fri, Aug 28th 2009 ] - Market Wire

[ Thu, Aug 27th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire
[ Thu, Aug 27th 2009 ] - Market Wire

[ Wed, Aug 26th 2009 ] - Market Wire
[ Wed, Aug 26th 2009 ] - Market Wire
[ Wed, Aug 26th 2009 ] - Market Wire
[ Wed, Aug 26th 2009 ] - Market Wire

[ Tue, Aug 25th 2009 ] - Market Wire
[ Tue, Aug 25th 2009 ] - Market Wire
[ Tue, Aug 25th 2009 ] - Market Wire
[ Tue, Aug 25th 2009 ] - Market Wire
[ Tue, Aug 25th 2009 ] - Market Wire
[ Tue, Aug 25th 2009 ] - Market Wire

[ Mon, Aug 24th 2009 ] - Market Wire
[ Mon, Aug 24th 2009 ] - Market Wire
[ Mon, Aug 24th 2009 ] - Market Wire
[ Mon, Aug 24th 2009 ] - Market Wire
[ Mon, Aug 24th 2009 ] - Market Wire
[ Mon, Aug 24th 2009 ] - Market Wire

[ Sun, Aug 23rd 2009 ] - Market Wire

[ Fri, Aug 21st 2009 ] - Market Wire
[ Fri, Aug 21st 2009 ] - Market Wire
[ Fri, Aug 21st 2009 ] - Market Wire

[ Thu, Aug 20th 2009 ] - Market Wire
[ Thu, Aug 20th 2009 ] - Market Wire
[ Thu, Aug 20th 2009 ] - Market Wire
[ Thu, Aug 20th 2009 ] - Market Wire
[ Thu, Aug 20th 2009 ] - Market Wire
[ Thu, Aug 20th 2009 ] - Market Wire

[ Wed, Aug 19th 2009 ] - Market Wire
[ Wed, Aug 19th 2009 ] - Market Wire
[ Wed, Aug 19th 2009 ] - Market Wire
[ Wed, Aug 19th 2009 ] - Market Wire

[ Tue, Aug 18th 2009 ] - Market Wire
[ Tue, Aug 18th 2009 ] - Market Wire
[ Tue, Aug 18th 2009 ] - Market Wire

[ Mon, Aug 17th 2009 ] - Market Wire
[ Mon, Aug 17th 2009 ] - Market Wire
[ Mon, Aug 17th 2009 ] - Market Wire
[ Mon, Aug 17th 2009 ] - Market Wire
[ Mon, Aug 17th 2009 ] - Market Wire
[ Mon, Aug 17th 2009 ] - Market Wire

[ Sun, Aug 16th 2009 ] - Market Wire

[ Fri, Aug 14th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire
[ Fri, Aug 14th 2009 ] - Market Wire

[ Thu, Aug 13th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire

[ Wed, Aug 12th 2009 ] - Market Wire
[ Wed, Aug 12th 2009 ] - Market Wire
[ Wed, Aug 12th 2009 ] - Market Wire
[ Wed, Aug 12th 2009 ] - Market Wire
[ Wed, Aug 12th 2009 ] - Market Wire
[ Wed, Aug 12th 2009 ] - Market Wire

[ Tue, Aug 11th 2009 ] - Market Wire
[ Tue, Aug 11th 2009 ] - Market Wire
[ Tue, Aug 11th 2009 ] - Market Wire
[ Tue, Aug 11th 2009 ] - Market Wire
[ Tue, Aug 11th 2009 ] - Market Wire
[ Tue, Aug 11th 2009 ] - Market Wire

[ Mon, Aug 10th 2009 ] - Market Wire
[ Mon, Aug 10th 2009 ] - Market Wire
[ Mon, Aug 10th 2009 ] - Market Wire
[ Mon, Aug 10th 2009 ] - Market Wire
[ Mon, Aug 10th 2009 ] - Market Wire
[ Mon, Aug 10th 2009 ] - Market Wire

[ Fri, Aug 07th 2009 ] - Market Wire

[ Thu, Aug 06th 2009 ] - Market Wire
[ Thu, Aug 06th 2009 ] - Market Wire
[ Thu, Aug 06th 2009 ] - Market Wire
[ Thu, Aug 06th 2009 ] - Market Wire
[ Thu, Aug 06th 2009 ] - Market Wire

[ Wed, Aug 05th 2009 ] - Market Wire
[ Wed, Aug 05th 2009 ] - Market Wire
[ Wed, Aug 05th 2009 ] - Market Wire
[ Wed, Aug 05th 2009 ] - Market Wire
[ Wed, Aug 05th 2009 ] - Market Wire

[ Tue, Aug 04th 2009 ] - Market Wire
[ Tue, Aug 04th 2009 ] - Market Wire
[ Tue, Aug 04th 2009 ] - Market Wire
[ Tue, Aug 04th 2009 ] - Market Wire
[ Tue, Aug 04th 2009 ] - Market Wire

[ Mon, Aug 03rd 2009 ] - Market Wire
[ Mon, Aug 03rd 2009 ] - Market Wire
[ Mon, Aug 03rd 2009 ] - Market Wire
[ Mon, Aug 03rd 2009 ] - Market Wire
[ Mon, Aug 03rd 2009 ] - Market Wire

[ Sat, Aug 01st 2009 ] - Market Wire

[ Fri, Jul 31st 2009 ] - Market Wire
[ Fri, Jul 31st 2009 ] - Market Wire
[ Fri, Jul 31st 2009 ] - Market Wire
[ Fri, Jul 31st 2009 ] - Market Wire
[ Fri, Jul 31st 2009 ] - Market Wire

[ Thu, Jul 30th 2009 ] - Market Wire
[ Thu, Jul 30th 2009 ] - Market Wire
[ Thu, Jul 30th 2009 ] - Market Wire
[ Thu, Jul 30th 2009 ] - Market Wire
[ Thu, Jul 30th 2009 ] - Market Wire

[ Wed, Jul 29th 2009 ] - Market Wire
[ Wed, Jul 29th 2009 ] - Market Wire
[ Wed, Jul 29th 2009 ] - Market Wire
[ Wed, Jul 29th 2009 ] - Market Wire
[ Wed, Jul 29th 2009 ] - Market Wire

[ Tue, Jul 28th 2009 ] - Market Wire
[ Tue, Jul 28th 2009 ] - Market Wire
[ Tue, Jul 28th 2009 ] - Market Wire
[ Tue, Jul 28th 2009 ] - Market Wire
[ Tue, Jul 28th 2009 ] - Market Wire

[ Mon, Jul 27th 2009 ] - Market Wire
[ Mon, Jul 27th 2009 ] - Market Wire
[ Mon, Jul 27th 2009 ] - Market Wire
[ Mon, Jul 27th 2009 ] - Market Wire
[ Mon, Jul 27th 2009 ] - Market Wire

[ Sat, Jul 25th 2009 ] - Market Wire

[ Fri, Jul 24th 2009 ] - Market Wire
[ Fri, Jul 24th 2009 ] - Market Wire

[ Thu, Jul 23rd 2009 ] - Market Wire
[ Thu, Jul 23rd 2009 ] - Market Wire
[ Thu, Jul 23rd 2009 ] - Market Wire
[ Thu, Jul 23rd 2009 ] - Market Wire
Labopharm comments on judgment in Purdue patent litigation
//health-fitness.news-articles.net/content/2009/ .. nts-on-judgment-in-purdue-patent-litigation.html
Published in Health and Fitness on Monday, August 17th 2009 at 6:04 GMT, Last Modified on 2009-08-17 06:04:55 by Market Wire
Published in Health and Fitness on Monday, August 17th 2009 at 6:04 GMT, Last Modified on 2009-08-17 06:04:55 by Market Wire

LAVAL, QC, Aug. 17 /CNW/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today commented on the outcome of patent-infringement litigation initiated by Purdue Pharma Products L.P. against Par Pharmaceutical Companies, Inc. relating to Ultram(R) ER (tramadol hydrochloride extended-release tablets). The patents-in-suit are owned by Purdue and are licensed to Ortho-McNeil, Inc., the marketer of Ultram(R) ER. In his decision, Circuit Judge Kent Jordan entered judgment in favor of Purdue and against Par on the issue of infringement and rejected Par's claim that the patents were unenforceable for inequitable conduct. Judge Jordan, however, entered judgment in favor of Par and against Purdue on the issue of validity, citing obviousness. This judgment could permit Par to market its generic formulation of Ultram ER in the U.S., should it receive final regulatory approval from the U.S. Food and Drug Administration. Although Labopharm is not a party to this action, if Par was to launch its generic formulation of Ultram ER, it could impact U.S. sales of Labopharm's own once-daily tramadol product, Ryzolt(TM), which is marketed in the U.S. by Purdue. Ultram ER, and therefore any generic version of it, is not A/B rated to Ryzolt, meaning it cannot be substituted for Ryzolt at the pharmacy. Labopharm is currently in discussions with Purdue to evaluate next steps in this matter, including a potential appeal of the decision. About Labopharm Inc. Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets and Australia. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review in the U.S. by the FDA. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit [ www.labopharm.com ]. Ryzolt(TM) is a trademark of Purdue Pharma Products L.P. This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process in various countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.
For further information: At Labopharm: Mark D'Souza, Senior Vice-President and Chief Financial Officer, Tel: (450) 686-0207; At The Equicom Group: Jason Hogan, Media and Investor Relations, Tel: (416) 815-0700, [ jhogan@equicomgroup.com ]; French: Joe Racanelli, Tel: (514) 844-7997, [ jracanelli@equicomgroup.com ]
Publication Contributing Sources
Similar Health and Fitness Publications
[ Sun, Aug 16th 2009 ] - Market Wire
[ Thu, Aug 13th 2009 ] - Market Wire
[ Tue, Aug 11th 2009 ] - Market Wire
[ Tue, Aug 11th 2009 ] - Market Wire
[ Wed, Aug 05th 2009 ] - Market Wire
[ Thu, Jul 30th 2009 ] - Market Wire
[ Mon, Jul 27th 2009 ] - Market Wire
[ Mon, Jul 20th 2009 ] - Market Wire
[ Thu, Jul 16th 2009 ] - Market Wire
[ Thu, Jun 25th 2009 ] - Market Wire
[ Wed, May 27th 2009 ] - Market Wire